{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:28:40Z","timestamp":1785270520027,"version":"3.55.0"},"reference-count":41,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2019,7,28]],"date-time":"2019-07-28T00:00:00Z","timestamp":1564272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) and fibromyalgia (FM) are two relatively common disorders that are considered distinct diagnoses. The aim of this study was to investigate the epidemiological characteristics of patients with both PD and FM, as well as their comorbidities and medication use. We performed a population-based retrospective cohort study in Israel from 2000 to 2015. We identified patients with PD according to a refined medication tracer algorithm and patients with FM according to their medical records. Using the algorithm, we identified 2606 patients diagnosed with PD, 60 of them (2.3%) were also diagnosed with FM. Most of the patients were females (88.3%) and the mean age of FM diagnosis was 63.95 \u00b1 12.27 years. These patients had a higher prevalence of depression, anxiety, and dementia. Of the patients diagnosed with PD + FM, 46 (76.7%) were diagnosed with FM after the diagnosis of PD. Patients with PD + FM used analgesics of distinct kinds in higher rates, as well as more anti-PD medications. We suggest that patients with PD + FM represent a distinct subgroup with a fibromyalgia-like syndrome associated with Parkinson\u2019s disease (FLISPAD). Their PD is more treatment resistant, and they take more medications, both analgesics and anti-PD.<\/jats:p>","DOI":"10.3390\/jcm8081118","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T03:06:58Z","timestamp":1564369618000},"page":"1118","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Fibromyalgia-Like Syndrome Associated with Parkinson\u2019s Disease\u2014A Cohort Study"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7031-6498","authenticated-orcid":false,"given":"Ran","family":"Abuhasira","sequence":"first","affiliation":[{"name":"Clinical Research Center, Soroka University Medical Center, Beer Sheva, Israel"},{"name":"Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Zlotnik","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel"},{"name":"Department of Neurology, Soroka University Medical Center, Beer Sheva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Horev","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel"},{"name":"Department of Neurology, Soroka University Medical Center, Beer Sheva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gal","family":"Ifergane","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel"},{"name":"Department of Neurology, Soroka University Medical Center, Beer Sheva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,7,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson\u2019s disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JPD-150685","article-title":"The concept of prodromal Parkinson\u2019s disease","volume":"5","author":"Mahlknecht","year":"2015","journal-title":"J. Parkinsons. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archneurol.2008.2","article-title":"Pain as a nonmotor symptom of Parkinson disease: Evidence from a case-control study","volume":"65","author":"Defazio","year":"2008","journal-title":"Arch. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/ene.12197","article-title":"Preceding pain symptoms and Parkinson\u2019s disease: A nationwide population-based cohort study","volume":"20","author":"Lin","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2147\/JMDH.S105857","article-title":"Pain management in patients with Parkinson\u2019s disease: Challenges and solutions","volume":"9","author":"Skogar","year":"2016","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/mds.22142","article-title":"Chronic pain in Parkinson\u2019s disease: The cross-sectional French DoPaMiP survey","volume":"23","author":"Regragui","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.parkreldis.2018.06.001","article-title":"A detailed clinical study of pain in 1957 participants with early\/moderate Parkinson\u2019s disease","volume":"56","author":"Silverdale","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: A clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA\u2014J. Am. Med. Assoc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jbspin.2007.09.010","article-title":"Pathogenesis of fibromyalgia\u2014A review","volume":"75","author":"Ablin","year":"2008","journal-title":"Jt. Bone Spine"},{"key":"ref_12","first-page":"584573","article-title":"The prevalence of fibromyalgia in other chronic pain conditions","volume":"2012","author":"Yunus","year":"2012","journal-title":"Pain Res. Treat."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/jnnp-2013-305911","article-title":"Can stress trigger Parkinson\u2019s disease?","volume":"85","author":"Djamshidian","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.pain.2007.05.010","article-title":"Striatal grey matter increase in patients suffering from fibromyalgia\u2014A voxel-based morphometry study","volume":"132","author":"Luerding","year":"2007","journal-title":"Pain"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jpain.2006.05.014","article-title":"Reduced Presynaptic Dopamine Activity in Fibromyalgia Syndrome Demonstrated With Positron Emission Tomography: A Pilot Study","volume":"8","author":"Wood","year":"2007","journal-title":"J. Pain"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.parkreldis.2006.05.001","article-title":"Parkinson disease patient with fibromyalgia: A case report","volume":"13","author":"Toda","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_17","unstructured":"(2018, June 16). Israel National Insurance Institute HMOs report 2015, Available online: https:\/\/www.btl.gov.il\/Publications\/survey\/Documents\/seker_280.pdf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JPD-2011-11024","article-title":"Use of a refined drug tracer algorithm to estimate prevalence and incidence of Parkinson\u2019s disease in a large israeli population","volume":"1","author":"Giladi","year":"2011","journal-title":"J. Parkinsons. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3899\/jrheum.080468","article-title":"Accuracy of the diagnosis of fibromyalgia by family physicians: Is the pendulum shifting?","volume":"36","author":"Shleyfer","year":"2009","journal-title":"J. Rheumatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia topical collection on fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_21","first-page":"39","article-title":"Prevalence of fibromyalgia in the Israeli population: A population-based study to estimate the prevalence of fibromyalgia in the Israeli population using the London Fibromyalgia Epidemiology Study Screening Questionnaire (LFESSQ)","volume":"30","author":"Ablin","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.38905","article-title":"The prevalence of fibromyalgia in the general population: A comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria","volume":"67","author":"Jones","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis Rheum."},{"key":"ref_24","unstructured":"Israeli Ministry of Health Rates of Smoking in Israel, Ministry of Health (2018, June 24). Part of \u201cHealth Knowledge, Attitudes and Behavior in Israel 2013\u201d, Available online: https:\/\/www.health.gov.il\/English\/Topics\/KHealth\/smoking\/Pages\/SmokingRatesInIsrael.aspx."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.archger.2015.08.004","article-title":"Association between cigarette smoking and Parkinson\u2019s disease: A meta-analysis","volume":"61","author":"Li","year":"2015","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1212\/WNL.0000000000000879","article-title":"Parkinson disease and smoking revisited: Ease of quitting is an early sign of the disease","volume":"83","author":"Ritz","year":"2014","journal-title":"Neurology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00296-009-0851-5","article-title":"The frequency of smoking in fibromyalgia patients and its association with symptoms","volume":"29","author":"Pamuk","year":"2009","journal-title":"Rheumatol. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/papr.12402","article-title":"The Perception of Female Smokers with Fibromyalgia on the Effects of Smoking on Fibromyalgia Symptoms","volume":"16","author":"Weingarten","year":"2016","journal-title":"Pain Pract."},{"key":"ref_29","first-page":"1570","article-title":"The London fibromyalgia epidemiology study: The prevalence of fibromyalgia syndrome in London, Ontario","volume":"26","author":"White","year":"1999","journal-title":"J. Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"127.e1","DOI":"10.1016\/j.ejpain.2009.03.010","article-title":"Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain","volume":"14","author":"Gormsen","year":"2010","journal-title":"Eur. J. Pain"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res. (Hoboken)."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1620\/tjem.222.1","article-title":"Prevalence, Classification, and Etiology of Pain in Parkinson\u2019s Disease: Association between Parkinson\u2019s Disease and Fibromyalgia or Chronic Widespread Pain","volume":"222","author":"Toda","year":"2010","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/j.pain.0000000000000631","article-title":"Does association of opioid use with pain and function differ by fibromyalgia or widespread pain status?","volume":"157","author":"Turner","year":"2016","journal-title":"Pain"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.amjmed.2011.05.031","article-title":"Opioid Use, Misuse, and Abuse in Patients Labeled as Fibromyalgia","volume":"124","author":"Fitzcharles","year":"2011","journal-title":"Am. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.clinthera.2013.09.001","article-title":"Antiparkinson drug use and adherence in medicare part D beneficiaries with parkinson\u2019s disease","volume":"35","author":"Wei","year":"2013","journal-title":"Clin. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/0891988706286512","article-title":"Patterns of initial pharmacotherapy for Parkinson\u2019s disease in the United States","volume":"19","author":"Huse","year":"2006","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/art.37739","article-title":"Central pain mechanisms in the rheumatic diseases: Future directions","volume":"65","author":"Phillips","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.parkreldis.2012.11.009","article-title":"Pain in Parkinson disease: A review of the literature","volume":"19","author":"Fil","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/mds.22716","article-title":"Pain in Parkinson\u2019s Disease","volume":"25","author":"Ford","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/pds.624","article-title":"Estimation of incidence and prevalence of Parkinson\u2019s disease in the elderly using pharmacy records","volume":"10","author":"Roos","year":"2001","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mds.22283","article-title":"Optimizing algorithms to identify Parkinson\u2019s disease cases within an administrative database","volume":"24","author":"Szumski","year":"2009","journal-title":"Mov. Disord."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/8\/1118\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:10:34Z","timestamp":1760188234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/8\/8\/1118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,28]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["jcm8081118"],"URL":"https:\/\/doi.org\/10.3390\/jcm8081118","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,28]]}}}